<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05091814</url>
  </required_header>
  <id_info>
    <org_study_id>10621</org_study_id>
    <nct_id>NCT05091814</nct_id>
  </id_info>
  <brief_title>Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.</brief_title>
  <official_title>: Post-operative Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.(a Cross Sectional Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating the prevalence of trismus among maxillary cancer patients in&#xD;
      the Egyptian population and the effect of radiotherapy on the occurrence of trismus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The enrolled participants who meet the eligibility criteria and signed the informed consent&#xD;
      of participation in the study will undergo clinical examination to determine the maximum&#xD;
      mouth opening after performing surgery only and /or after radiotherapy in case of adjuvant&#xD;
      therapy&#xD;
&#xD;
      the maximum mouth opening will be measured in (mm) by using a digital caliper device and will&#xD;
      be recorded in the patient sheet,&#xD;
&#xD;
      reading of less than 35mm will be considered trismus while above 35mm or more will be&#xD;
      considered normal (NO trismus)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>% prevalence</measure>
    <time_frame>1 year</time_frame>
    <description>Trismus prevalence in percent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MMO</measure>
    <time_frame>1 year</time_frame>
    <description>maximum mouth opening</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Maxillary Neoplasms</condition>
  <arm_group>
    <arm_group_label>Radiotherapy (Yes or no) - Exercise (YES or NO)</arm_group_label>
    <description>with or without radiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MMO (in mm)</arm_group_label>
    <description>with or without radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiotherapy</intervention_name>
    <description>patients who recieved radiotherapy after surgical removal of the tumor</description>
    <arm_group_label>Radiotherapy (Yes or no) - Exercise (YES or NO)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with maxillary cancer attending faculty of dentistry ,CU and the national cancer&#xD;
        institute.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with maxillary cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients under 18 yrs .&#xD;
&#xD;
          -  patients with TMJ disorders before surgery&#xD;
&#xD;
          -  patients on chemotherapy&#xD;
&#xD;
          -  - Tumors in other sites( Tongue , buccal mucosa , salivary glands, mandible)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gamal Ashour</last_name>
    <role>Study Director</role>
    <affiliation>National Cancer Institute (NCI)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erfan</last_name>
    <phone>01111594776</phone>
    <phone_ext>12511</phone_ext>
    <email>mohamed.diaa@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Khashab</last_name>
    <phone>01006611525</phone>
    <phone_ext>12511</phone_ext>
    <email>mohamed.elkhashab@dentistry.cu.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Haram</state>
        <zip>12511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed erfan</last_name>
      <phone>01111594776</phone>
      <email>mohamed.diaa@dentistry.cu.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed khashab</last_name>
      <phone>01006611525</phone>
      <email>mohamed.elkhashab@dentistry.cu.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>van der Geer SJ, van Rijn PV, Kamstra JI, Langendijk JA, van der Laan BFAM, Roodenburg JLN, Dijkstra PU. Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study. Head Neck. 2019 Jan;41(1):64-71. doi: 10.1002/hed.25369. Epub 2018 Dec 18.</citation>
    <PMID>30561067</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 26, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Diaa Eldin Erfan</investigator_full_name>
    <investigator_title>: Post-operative Prevalence of trismus in patients with maxillary cancer with and without radiation therapy in the Egyptian population.(a cross sectional study)</investigator_title>
  </responsible_party>
  <keyword>surgery , Trismus, Oral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Maxillary Neoplasms</mesh_term>
    <mesh_term>Trismus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>the results of the study will be available at the college library for the researchers to benefit from.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1-2 years</ipd_time_frame>
    <ipd_access_criteria>Free access</ipd_access_criteria>
    <ipd_url>http://clinicaltrials.gov</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

